Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Lactamases | 7 | 2023 | 84 | 1.600 |
Why?
|
| Bacterial Proteins | 6 | 2023 | 77 | 1.500 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2011 | 64 | 1.060 |
Why?
|
| Gram-Negative Bacteria | 3 | 2023 | 29 | 0.940 |
Why?
|
| Pseudomonas Infections | 3 | 2011 | 50 | 0.800 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2018 | 9 | 0.720 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2018 | 24 | 0.710 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 29 | 0.690 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 376 | 0.680 |
Why?
|
| Carrier State | 2 | 2017 | 49 | 0.670 |
Why?
|
| Drug Resistance, Microbial | 1 | 2020 | 66 | 0.670 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 36 | 0.660 |
Why?
|
| Betacoronavirus | 1 | 2020 | 77 | 0.640 |
Why?
|
| Cross Infection | 6 | 2019 | 282 | 0.610 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 90 | 0.610 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 94 | 0.610 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 37 | 0.600 |
Why?
|
| Bacteriological Techniques | 1 | 2017 | 17 | 0.560 |
Why?
|
| beta-Lactam Resistance | 1 | 2017 | 14 | 0.560 |
Why?
|
| Klebsiella Infections | 4 | 2019 | 54 | 0.520 |
Why?
|
| Klebsiella pneumoniae | 4 | 2019 | 59 | 0.510 |
Why?
|
| Specimen Handling | 3 | 2023 | 44 | 0.360 |
Why?
|
| Carbapenems | 4 | 2023 | 39 | 0.330 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2018 | 53 | 0.300 |
Why?
|
| Humans | 16 | 2023 | 28560 | 0.290 |
Why?
|
| Time Factors | 4 | 2020 | 1501 | 0.290 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 519 | 0.260 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2023 | 86 | 0.260 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 181 | 0.250 |
Why?
|
| Infection Control | 2 | 2014 | 166 | 0.210 |
Why?
|
| Long-Term Care | 3 | 2017 | 58 | 0.180 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2020 | 6 | 0.180 |
Why?
|
| Nasopharynx | 1 | 2020 | 5 | 0.180 |
Why?
|
| Rectum | 2 | 2017 | 45 | 0.170 |
Why?
|
| HIV-1 | 1 | 2022 | 236 | 0.170 |
Why?
|
| Phage Therapy | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hospitals | 5 | 2019 | 156 | 0.160 |
Why?
|
| Bacteremia | 1 | 2019 | 101 | 0.150 |
Why?
|
| Pandemics | 1 | 2020 | 260 | 0.150 |
Why?
|
| HIV Infections | 1 | 2022 | 488 | 0.140 |
Why?
|
| Feces | 1 | 2017 | 107 | 0.130 |
Why?
|
| Middle Aged | 6 | 2020 | 9316 | 0.130 |
Why?
|
| Bacteria | 1 | 2017 | 74 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2017 | 110 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 496 | 0.130 |
Why?
|
| Enterobacteriaceae | 1 | 2015 | 42 | 0.120 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2015 | 48 | 0.120 |
Why?
|
| Aged | 5 | 2020 | 9334 | 0.120 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 18 | 0.110 |
Why?
|
| United States | 1 | 2020 | 2197 | 0.110 |
Why?
|
| Male | 6 | 2020 | 15400 | 0.110 |
Why?
|
| Female | 6 | 2020 | 15818 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 159 | 0.100 |
Why?
|
| Adult | 3 | 2020 | 8168 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2017 | 1807 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2011 | 10 | 0.090 |
Why?
|
| Plasmids | 1 | 2011 | 47 | 0.090 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 58 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 184 | 0.090 |
Why?
|
| Mutation | 1 | 2011 | 353 | 0.080 |
Why?
|
| Chicago | 3 | 2017 | 939 | 0.070 |
Why?
|
| Virus Shedding | 1 | 2023 | 5 | 0.050 |
Why?
|
| Respiratory System | 1 | 2023 | 7 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 45 | 0.050 |
Why?
|
| HIV Antigens | 1 | 2022 | 11 | 0.050 |
Why?
|
| HIV Antibodies | 1 | 2022 | 16 | 0.050 |
Why?
|
| HIV-2 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Immunoassay | 1 | 2022 | 40 | 0.050 |
Why?
|
| ROC Curve | 1 | 2019 | 144 | 0.040 |
Why?
|
| Oregon | 1 | 2018 | 2 | 0.040 |
Why?
|
| Spain | 1 | 2018 | 9 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 11 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 352 | 0.040 |
Why?
|
| Illinois | 1 | 2018 | 247 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 44 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 58 | 0.030 |
Why?
|
| Temperature | 1 | 2017 | 66 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 54 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 53 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 276 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 32 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 4894 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 501 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 53 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 599 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1395 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2015 | 129 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 21 | 0.030 |
Why?
|
| Hospital Administration | 1 | 2014 | 24 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 66 | 0.030 |
Why?
|
| Focus Groups | 1 | 2014 | 93 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2014 | 81 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 467 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 126 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 601 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 2412 | 0.020 |
Why?
|